BEAMBeam Therapeutics Inc.vs its industry peers
A metric-by-metric comparison of Beam Therapeutics Inc. against ARK Innovation ETF holdings — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BEAM본 종목 | $2.7B#7 | — | 2.3x#1 | 19.3x#3 | 120.0%#2 | 78.8%#3 | -274.6%#6 | -6.9%#6 | -39.3%#5 | — | 31.5%#2 | — |
| TSLA | $1.21T#2 | 284.5x#4 | 14.0x#6 | 12.8x#2 | -2.9%#6 | -46.5%#5 | 4.6%#4 | 4.4%#4 | 4.3%#3 | 5#2 | — | — |
| AMD | $721.3B#3 | 145.0x#3 | 11.2x#5 | 20.8x#4 | 34.3%#4 | 164.2%#2 | 10.7%#3 | 6.7%#3 | 6.0%#2 | 7#1 | 149.3%#1 | — |
| CRSP | $4.6B#6 | — | 2.5x#2 | 1307.1x#7 | -90.6%#7 | -58.8%#6 | -18933.6%#7 | -32.1%#7 | -33.6%#4 | — | -19.4%#4 | — |
| CRCL | $15.7B#5 | — | 4.6x#3 | 142.9x#6 | 624.0%#1 | -144.7%#7 | -87.8%#5 | -2.0%#5 | — | — | -64.6%#5 | — |
| PLTR | $296.1B#4 | 138.8x#2 | 35.0x#7 | 66.2x#5 | 56.2%#3 | 251.6%#1 | 31.6%#1 | 19.2%#2 | — | — | — | — |
| AMZN | $2.48T#1 | 27.6x#1 | 5.6x#4 | 3.5x#1 | 12.4%#5 | 16.9%#4 | 11.2%#2 | 20.5%#1 | 14.0%#1 | 5#2 | -0.1%#3 | — |
Peer set: top holdings of ARKK (ARK Innovation ETF), the indexed fund holding this stock at its highest weight — a fund manager's grouping, not Tickwind's judgement. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-07-29.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice